Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors

Por Clynes, Raphael, Calvani, Nicola, Croker, Byron P, Richards, Hanno B
Publicado em 2005

Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus

Por Richards, Hanno B., Satoh, Minoru, Shaw, Melody, Libert, Claude, Poli, Valeria, Reeves, Westley H.
Publicado em 1998

Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus

Por Li, Yi, Lee, Pui Y, Sobel, Eric S, Narain, Sonali, Satoh, Minoru, Segal, Mark S, Reeves, Westley H, Richards, Hanno B
Publicado em 2009

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases

Por Yamasaki, Yoshioki, Narain, Sonali, Hernandez, Liza, Barker, Tolga, Ikeda, Keigo, Segal, Mark S, Richards, Hanno B, Chan, Edward KL, Reeves, Westley H, Satoh, Minoru
Publicado em 2006

Effect of Secukinumab on Patient‐Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)

Por Deodhar, Atul A., Dougados, Maxime, Baeten, Dominique L., Cheng‐Chung Wei, James, Geusens, Piet, Readie, Aimee, Richards, Hanno B., Martin, Ruvie, Porter, Brian
Publicado no Arthritis Rheumatol (2016)

Effect of an Exogenous Trigger on the Pathogenesis of Lupus in (NZB × NZW)F(1) Mice

Por Yoshida, Hideo, Satoh, Minoru, Behney, Krista M., Lee, Chee-Gun, Richards, Hanno B., Shaheen, Victoria M., Yang, Jun-Qi, Singh, Ram R., Reeves, Westley H.
Publicado em 2002

Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis

Por van der Heijde, Désirée, Landewé, Robert B., Mease, Philip J., McInnes, Iain B., Conaghan, Philip G., Pricop, Luminita, Ligozio, Greg, Richards, Hanno B., Mpofu, Shephard
Publicado no Arthritis Rheumatol (2016)